MyFinsight
Home
Blog
About
Cash and cash
equivalents
$360,212K
(65.39%↑ Y/Y)
Accounts receivable, net
$274,469K
(21.63%↑ Y/Y)
Inventories
$143,149K
(3.49%↑ Y/Y)
Prepaid expenses and
other current assets
$31,942K
(111.40%↑ Y/Y)
Investment in equity
securities
$15,626K
(173.28%↑ Y/Y)
Restricted cash
$35K
(-2.78%↓ Y/Y)
Total current assets
$825,433K
(36.97%↑ Y/Y)
Intangible assets, net
$449,857K
(-13.54%↓ Y/Y)
Property and equipment,
net
$73,223K
(23.59%↑ Y/Y)
Deferred tax assets, net
$71,495K
(-22.31%↓ Y/Y)
Goodwill
$62,480K
(3.22%↑ Y/Y)
Other non-current
assets
$11,624K
(40.97%↑ Y/Y)
Total assets
$1,494,112K
(11.25%↑ Y/Y)
Total liabilities and
stockholders equity
$1,494,112K
(11.25%↑ Y/Y)
Total liabilities
$896,900K
(1.76%↑ Y/Y)
Total stockholders
equity
$597,212K
(36.74%↑ Y/Y)
Treasury stock, 891,915
shares of common stock,...
$53,817K
(70.34%↑ Y/Y)
Accumulated other
comprehensive (loss) income,...
-$327K
(-109.87%↓ Y/Y)
Convertible notes, net
$309,009K
(0.70%↑ Y/Y)
Total current
liabilities
$283,655K
(19.77%↑ Y/Y)
Debt, net
$280,155K
(-7.07%↓ Y/Y)
Other non-current
liabilities
$15,535K
(132.00%↑ Y/Y)
Contingent consideration
$8,546K
(-52.76%↓ Y/Y)
Additional paid-in capital
$620,249K
(14.46%↑ Y/Y)
Retained earnings
(accumulated deficit)
$31,104K
(140.47%↑ Y/Y)
Common stock, 0.0001
par value,...
$3K
(50.00%↑ Y/Y)
Accounts payable
$73,830K
(35.30%↑ Y/Y)
Accrued royalties
$55,830K
(54.95%↑ Y/Y)
Returned goods reserve
$44,013K
(-9.59%↓ Y/Y)
Accrued government
rebates
$41,392K
(25.94%↑ Y/Y)
Accrued compensation
and related...
$27,154K
(-17.55%↓ Y/Y)
Current debt, net
$21,329K
(61.39%↑ Y/Y)
Accrued expenses and
other
$16,575K
(12.29%↑ Y/Y)
Income taxes payable
$3,532K
(7.23%↑ Y/Y)
Back
Back
Balance Sheet
ANI PHARMACEUTICALS INC (ANIP)
ANI PHARMACEUTICALS INC (ANIP)
source: myfinsight.com